Announcements Trials
Browse Landscape

Phase

Phase 1 18Phase 3 11Phase 2 10Phase 1/2 7Phase NA 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 6Prostatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Stomach Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Cholangiocarcinoma 3Breast Neoplasms 3Weight Loss 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Recurrence 2Myasthenia Gravis 2Mouth Neoplasms 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma 2Cachexia 2Anorexia 2

Interventions

atezolizumab 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × 30 days × Clear all
NCT07226999 2026-06-04

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Pfizer

Phase 2/3 Recruiting
550 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡